HomeZVSA • NASDAQ
add
Zyversa Therapeutics Inc
Previous close
$2.26
Day range
$2.16 - $2.35
Year range
$1.90 - $46.92
Market cap
2.37M USD
Avg Volume
126.77K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.75M | -46.52% |
Net income | -2.76M | 96.48% |
Net profit margin | — | — |
Earnings per share | -3.31 | — |
EBITDA | -2.75M | 46.55% |
Effective tax rate | -0.35% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 119.49K | -47.75% |
Total assets | 19.47M | -39.13% |
Total liabilities | 10.85M | -9.03% |
Total equity | 8.62M | — |
Shares outstanding | 1.03M | — |
Price to book | 0.22 | — |
Return on assets | -33.49% | — |
Return on capital | -69.39% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -2.76M | 96.48% |
Cash from operations | -1.91M | -369.58% |
Cash from investing | — | — |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -1.91M | -82.40% |
Free cash flow | -793.49K | -217.80% |
About
Founded
2014
Headquarters
Website
Employees
7